Santen Pharmaceutical Co., Ltd. (SNPHF) Financials
SNPHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 3.0 billion | 920.7 million |
| 2023-09-30 | 2.9 billion | 806.9 million |
| 2023-06-30 | 2.9 billion | 804.7 million |
| 2023-03-31 | 3.2 billion | 962.8 million |
SNPHF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 213.3 million | ? |
| 2023-09-30 | 153.5 million | ? |
| 2023-06-30 | -2.7 million | ? |
| 2023-03-31 | 35.7 million | ? |
SNPHF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 51.8 million |
| 2023-09-30 | 59.3 million |
| 2023-06-30 | 72.0 million |
| 2023-03-31 | 8.3 million |
SNPHF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 591.1 million | - | - |
| 2023-09-30 | 444.2 million | - | - |
| 2023-06-30 | 325.8 million | - | - |
| 2023-03-31 | 441.8 million | - | - |
SNPHF Shares Outstanding
SNPHF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 11.5 million | 40.8 million | 153.0 million | - |
| 2023-09-30 | 15.1 million | 41.2 million | 148.0 million | - |
| 2023-06-30 | 20.3 million | 43.6 million | 145.7 million | - |
| 2023-03-31 | 29.6 million | 49.8 million | 231.5 million | - |
SNPHF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 546.2 million | 227.9 million |
| 2023-09-30 | 491.5 million | 197.0 million |
| 2023-06-30 | 500.8 million | 207.7 million |
| 2023-03-31 | 596.7 million | 207.1 million |
SNPHF
Price: $9.45
Dividend Yield: 2.49%
Forward Dividend Yield: 5.08%
Payout Ratio: 101.28%
Dividend Per Share: 0.48 USD
Earnings Per Share: 0.47 USD
P/E Ratio: 21.15
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 3.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 20
DGR3: -2.03%
DGR5: 30.00%
DGR10: 30.00%